Oliveto Joseph 4

What Happened
Joseph Oliveto, President, CEO and Director of Milestone Pharmaceuticals (MIST), reported the sale of 36,500 shares on April 16, 2026. The shares were disposed of at a weighted average price of $2.26 per share for total proceeds of approximately $82,490. The filing lists the transaction as an open-market or private sale (code S).

Key Details

• Transaction date: 2026-04-16 (reported on Form 4 filed 2026-04-20; filing is within the 2-business-day window)
• Price: weighted average $2.26; individual sale prices ranged from $2.25 to $2.28 (footnote indicates multiple trades within that range)
• Shares sold: 36,500; Proceeds: ~$82,490
• Post-transaction holdings: Not stated in the information provided in this summary (not included in supplied details)
• Notable footnote: Sale executed pursuant to a Rule 10b5-1 trading plan adopted by Oliveto on September 30, 2025. The filer offers to provide a breakdown of the number of shares sold at each specific price in the $2.25–$2.28 range upon request.

Context
This was a sale (code S). Sales executed under pre-established 10b5-1 plans are typically pre-planned and do not, by themselves, indicate a change in the insider’s view of the company. Retail investors may view purchases as stronger signals than routine sales, but this report is factual disclosure of the transaction only.